NFA
OPTR

Nationwide Fund Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Nationwide Fund Advisors’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-38,821
Closed -$489K – 3346
2013
Q3 		$489K Sell
38,821
-33,950
-47% -$450K ﹤0.01% 2231
2013
Q2 		$1.05M Buy
+72,771
New +$1.06M 0.01% 1650

Nationwide Fund Advisors's OPTR Position: Q4 2013 in Review

Nationwide Fund Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 38,821 shares — an estimated $489K sold.

Nationwide Fund Advisors first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $1.05M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Nationwide Fund Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Nationwide Fund Advisors sold 38,821 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $489K.
  • Nationwide Fund Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Nationwide Fund Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.05M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Nationwide Fund Advisors's 13F filing for Q4 2013, filed 7 Feb 2014.